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ABSTRACT  The role of structural signals in intercompartmental  transport has been addressed 
by the isolation  of yeast  invertase  (SUC2)  mutations that cause  intracellular accumulation  of 
active  enzyme.  Two  mutations  that  delay  transport  of  core-glycosylated  invertase,  but  not 
acid phosphatase,  have been mapped in the 5' coding region of SUC2. Both mutations reduce 
specifically the transport of invertase  to a compartment, presumably in the Golgi body, where 
outer chain  carbohydrate  is added.  Subsequent transport to the  cell  surface  is not similarly 
delayed.  One  mutation  (SUC2-sl)  converts  an  ala codon  to val  at  position  -1  in  the  signal 
peptide;  the  other  (SUC2-s2)  changes  a thr to an  lie  at  position  +64  in  the  mature  protein. 
Mutation  sl  results  in about a 50-fold  reduced  rate of invertase  transport to the Golgi  body 
which  is attributable  to defective  signal  peptide  cleavage.  While  peptide  cleavage  normally 
occurs  at  an  ala-ser  bond,  the  sl  mutant  form  is  processed  slowly at  the  adjacent  ser-met 
position giving rise to mature invertase  with an N-terminal  met residue, s2 mutant invertase  is 
transported about sevenfold more slowly than normal, with no delay in signal peptide cleavage, 
and no detectable abnormal physical property of the enzyme. This substitution  may interfere 
with the interaction of invertase  and a receptor that facilitates  transport to the Golgi body. 
The compartmentation of eucaryotic cells implies both spe- 
cific mechanisms for protein localization and identifying sig- 
nals that are recognized by the localization apparatus. Protein 
transport must be targeted not only to distinct organelles but 
to specific subdivisions within such organelles as the mito- 
chondrion, chloroplast, endoplasmic reticulum (ER), ~ Golgi 
body, and plasma membrane. This process probably involves 
a number of unique identifying signals  of which only a few 
have been deciphered. Clearly distinct N-terminal signal pep- 
tides direct secretory, mitochondrial, and chloroplast precur- 
sors to their respective organelles (1-3); hydrophobic mem- 
brane  anchoring  sequences  have  been  recognized in  viral 
glycoproteins (4,  5) and surface-bound immunoglobulin (6); 
a  cytoplasmic,  C-terminal  peptide  has  been implicated  in 
rapid transport of vesicular stomatitis virus G  protein from 
the ER (7); and oligosaccharide phosphorylation triggers the 
t Abbreviations  used in this paper."  E  and I  fractions, external and 
intraceilular fractions; endo H, endoglycosidase  H; ER, endoplasmic 
reticulum; YPD medium,  1% Bacto-Yeast extract, 2% Bacto-pep- 
tone, and 2% glucose  (YP medium, same but without glucose). 
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sorting of lysosomal enzymes in mammalian fibroblasts (8- 
10). 
A major question in the mechanism of secretion concerns 
the role of receptors in mediation of intracellular transport. 
The evidence for such  receptors is  entirely circumstantial. 
Two examples that are consistent with a receptor are that the 
rate of transport from the ER to the Golgi body varies for 
different proteins in the same cell ( 11-13), and that movement 
of retinol-binding protein from the ER requires retinol, pre- 
sumably to alter the conformation of  the binding protein (14). 
These  cases  could  equally  well  be  explained  by  selective 
negative influences on transport of slowly moving proteins. 
The challenge in this area is to develop evidence of a more 
positive nature, such as the identification of a signal or struc- 
ture required for transport. 
One method of defining localization signals in organellar 
proteins is the isolation of mutations in which these signals 
are defective so that the altered protein accumulates at some 
point along the normal transport pathway or is misdirected 
to some other cellular organelle. The most revealing applica- 
tion of this approach has been in the definition of important 
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( 15-17). In eucaryotic cells, numerous examples of transport- 
deficient mutant forms of membrane and secretory proteins 
have  been  presented:  IgA  k  light  chain  (18),  low-density 
lipoprotein receptor (19), Vaccinia Virus hemagglutinin (20), 
arantitrypsin (2 l), vesicular stomatitis virus G  protein (22- 
23, for review see reference 24). Defective proteins most often 
accumulate  in  the  ER.  Although some  of these  mutations 
may specifically affect  a transport signal, it has been difficult 
to exclude the more trivial  possibility that defective proteins 
are denatured or aggregated. 
Retention of full enzyme activity in a  secretion-defective 
mutant protein is a criterion that may be used to distinguish 
a transport lesion from more general perturbations of protein 
structure.  With this in mind, we have examined invertase, an 
enzyme that follows the normal secretory pathway in yeast 
(25).  The  invertase  gene  (SUC2)  has  been  cloned  and  se- 
quenced (26, 27). Transformation of yeast cells with heavily 
mutagenized plasmid  DNA  has allowed a  large  number of 
SUC2  mutants  to  be  screened  for accumulation  of active 
invertase. In this report we describe the isolation, characteri- 
zation, and precise mapping of two transport-specific muta- 
tions. 
MATERIALS  AND  METHODS 
Strains,  Growth  Conditions,  and  Materials:  Saccharomyces 
cerevisiae  strains  SEY2101, SEY2102, and  SEYS188 (all SUc2-A9),  and 
SEY5186 (SUC2, secl8), were described previously (28, 29). ISYl-22A  (urn3- 
52, leu2-3, leu2-112,  his4-519,  SUC2-A9, pho80-2) was constructed  by standard 
genetic techniques. 
pRB58, a YEp24-derived 2 u plasmid (30) containing  the SUC2 gene, was 
obtained  from M.  Carlson  (Columbia  University)  and  has been  described 
elsewhere  (26). Plasmids  pSEY125,  pSEY124,  and  pSEY122,  which  carry 
SUC2-1acZ fusions, have also been described elsewhere (29). pSEY8 was derived 
from pUC8 (31) and also contains 2 u DNA and the URA3 gene (30). 
YPD medium contained  1% Baeto-Yeast extract (Difco Laboratories Inc., 
Detroit,  MI),  2%  Bacto-peptone  (Difco  Laboratories  Inc.), and 2%  glucose. 
Wickerham's minimal medium (32) was used with various amounts of  glucose 
or raffinose as a carbon source. For low sulfate medium, chloride salts replaced 
sulfate salts, and ammonium sulfate was added  to the desired concentration. 
The absorbance  of dilute cell suspensions was measured in a  l-cm cuvette at 
600 nm in a Zeiss PMQII spectrophotometer,  10Dt,00 unit of  cells corresponds 
to 0.15 mg dry wt. Liquid cultures were grown in flasks or tubes with agitation, 
and experiments were initiated with exponentially growing cells at an OD~o of 
0.5-4. 
Other reagents were obtained  as indicated: glucose oxidase, peroxidase, o- 
dianisidine,  cycloheximide,  cytochrome  c,  NADPH,  ravin  mononucleotide, 
triphenyltetrazolium  chloride,  tunicamycin,  ATP,  saponin,  hydroxylamine, 
ergosterol, and tergitol Nonidet P-40 were from Sigma Chemical Co. (St. Louis, 
MO); H235SO4 and [3H]leucine were from Amersham Corp. (Arlington Heights, 
IL); ENHANCE was from New England Nuclear (Boston, MA); Beta Max was 
from West Chem (San Diego, CA); IgG Sorb was from The Enzyme Center 
Inc. (Boston, MA); restriction enzymes and T4 DNA ligase were from Bethesda 
Research  Laboratories  (Gaithersburg,  MD); oleate was from Merck and Co. 
(Rahway, N  J); BBL-Gas Pak anaerobic system catalyst and CO2 + H2 generator 
packs were from Fisher Scientific Co. (Pittsburgh,  PA). Lyticase (fraction  II) 
was used  for production  of spheroplasts.  Endoglycosidase H  (endo  H) was 
obtained from P. Robbins (Massachusetts Institute of Technology). Acid phos- 
phatase antibody  was obtained  from Simone Straumann-B6hni  and Gottfried 
Schatz (Biozentrum,  University of Basel). 
Cytoplasmic invertase was purified by the method of  Goldstein and Lampen 
(33) and used to raise antibody  by the multiple intradermal  injection method 
(34). Immune  serum, which had a titer of  about l:l 6 to 1:32 against cytoplasmic 
invertase, was stored  at -20"C (in  l0 mM NAN3) and used without  further 
purification.  Immune precipitation  samples were mixed  with aliquots  of an 
extract  prepared  from strain  SEY2102. This strain,  which  had no invertase 
cross-reacting material, was grown to late logarithmic phase in YPD medium; 
cells were centrifuged and resuspended in PBS (12.5 mM sodium phosphate, 
pH 7.0, 200 mM sodium chloride) at ~800 ODr0o  units of cells/ml and lysed 
by agitation for 5 min with glass beads (0.3-0.5  mm) in a Bead-Beater (Biospec 
Products,  Bartlesville, OK).  The extract  was then  adjusted  to  1%  SDS and 
heated in a boiling water bath for 6 min. A soluble fraction (30-40 mg protein/ 
ml) was obtained by centrifugtion for 20 min at 12,000 g. 
Mutagenesis  and  Mutant  Screening:  pRB58 plasmid DNA, 
purified by CsC1 density sedimentation,  was diluted into a solution  of 0.4 M 
hydroxylamine, 0.05 M potassium phosphate, pH 6.0, at a DNA concentration 
of 125 #g/ml. After 60 rain at 75"C, samples were chilled, and the DNA was 
precipitated  with ethanol,  resuspended  in  l0 mM Tris.HO, pH 7.5, 2 mM 
EDTA, and precipitated  with ethanol  an additional  two times.  Yeast strain 
SEY2102  was transformed  with  mutagenized  DNA by the  lithium  acetate 
procedure (35). Each petri plate (containing minimal medium without uracil) 
was spread with cells exposed to 2 #g of DNA. 
Individual  transformants were spotted  onto selective plates (minimal  me- 
dium without uracil) and screened for invertase secretion by one or both of 
two methods.  The first screen involved a qualitative  assay of invertase  on a 
filter paper disk. Plates of 100 transformants were stamped  in duplicate onto 
plates containing YP medium (no glucose) and incubated at room temperature 
for 3-4 h during which time invertase synthesis was derepressed. One of each 
pair of plates was inverted over a chloroform-soaked  paper towel for l0 min. 
Whatman No.  1 filter disks (Whatman Laboratory Products Inc., Clifton, N J) 
were bathed in a 2-ml solution that contained  the invertase assay reagents: 0. l 
M sodium acetate,  pH 5.1, 0.125 M sucrose, 0.4 mM N-ethylmaleimide,  l0 
~g/ml peroxidase, 0.6 mg/ml o-dianisidine, and 0.05 mg/ml glucose oxidase. 
Chloroform-treated  and untreated  copies of the transformants were stamped 
onto damp filters. Within  a few minutes at room temperature,  a pink color 
developed over most of  the patches. This procedure was used to identify mutant 
suc2-sl, which showed more intense staining in the chloroform-treated replica, 
but did not give sufficient resolution to detect the other mutants. 
The other screening procedure  involved analysis of intracellular  invertase 
activity by electrophoresis on nondenaturing polyacrylamide gels. Cultures (5 
ml)  of individual  transformants were  grown  to  mid-logarithmic  phase  in 
minimal medium + 5% glucose. A mixture of I ODr0o  unit of cells from each 
of five cultures were centrifuged, washed with water, and incubated in minimal 
medium and 0.1% glucose for 3 h at 25"C. Cells were then washed with  l0 
mM sodium azide, and  l ODt,~o  was resuspended in 0. l ml of 1.4 M sorbitol, 
50  mM  potassium  phosphate,  pH  7.5, 10  mM  sodium azide, 80  mM  2- 
mereaptoethanol,  and 50 U oflyticase.  After 60 min at 30"C, spheroplasts that 
sedimented  at  3,000  g  for  l0  rain  were lysed by  resuspension  in  50  mM 
potassium phosphate,  pH 7.5, l0 mM sodium azide, 0.1% Triton X-100. An 
aliquot corresponding to 0.15 OD~o0  unit of cells was electrophoresed on a 5% 
polyacrylamide  slab gel using a system described by Meyer and Motile (36) 
except without SDS. lnvertase was localized in the gel, after incubation at 25"C 
for 20-60 min in 0. l M sodium acetate (pH 5.0), 0. l M sucrose, by the method 
of Gabriel  and Wang (37). Pools containing  mixtures  of wild-type and suc- 
transformants showed  primarily  the  rapidly  and  discretely  migrating  cyto- 
plasmic invertase with faint staining in the region that contained  glycosylated 
forms of invertase.  In pools that showed more intense staining in this latter 
region, individual members were screened directly for invertase secretion and 
accumulation  by the assay of Goldstein and Lampen (33) with minor modifi- 
cations (38). A unit ofinvertase will release l #tool of  glucose from sucrose per 
minute at 25"C. 
Labeling,  Immunoprecipitation,  and  Endo  H  Treatment: 
Cells were grown to mid-logarithmic phase in minimal  medium + 5% glucose 
and 0.1  mM ammonium sulfate. 10Dr0o unit of cells was centrifuged, washed 
with water, and resuspended in fresh minimal medium + 0.1% glucose and no 
sulfate at l to 20D~o units ofcells/ml. These conditions allowed derepression 
of invertase synthesis. After 20 min at 25"C, 250 #Ci of carrier-f~ H23sSO4 
was added  and cultures  were incubated  an additional  30  min.  Labeled cells 
were washed and converted to spheroplasts as described in the previous section. 
Spheroplasts were centrifuged, the supernatant fractions were adjusted to 0.5% 
SDS, and the pellets were resuspeoded  in  50  t~l  of 1%  SDS. Samples were 
heated in boiling water for 3 min, diluted to l ml with PBS and 2% Triton X- 
100, and treated  with  25-50 ~l  of IgG Sorb, prepared  as described  by the 
manufacturer,  for 30 rain at 0*C. IgG Sorb was removed by centrifugation at 
12,000 g for 20 rain and supernatant  fractions were transferred to new micro- 
fuge tubes. Antibody was added (invertase serum, 4 #l/OD~o unit cell equiva- 
lent; acid phosphatase serum, 4 #l/ODr0o until cell equivalent for spheroplasts, 
and  100 t~l/ODt,  oo unit cell equivalent  for spheroplast  supernatant fractions) 
and samples were incubated  at 0*C for 2 h.  Invertase  immunoprecipitafion 
samples were supplemented  with  125 #l (4-5 mg protein)  of nonradioactive 
extract  from  strain  SEY2102;  this  served  to  compete  for precipitation  of 
unrelated  proteins.  IgG Sorb was added  at  10-20  ul per l  #l of serum,  and 
immune complexes formed during 30 min at 0*C were sedimented at 12,000 g 
for  l  min.  Complexes were washed twice with 0.5  ml of 2  M  urea, 0.2  M 
sodium chloride, 0.1  M Tris.HCl, pH 7.5, 1% Triton X-100, and then twice 
with 0.5 ml of 1% 2-mereaptoethanol.  Final pellets were resuspended in 25-50 
#l of sample buffer (50 mM Tris.HCl, pH 6.8, 10% glycerol, 1% SDS, 2% 2- 
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rain. After centrifugation  in a microfuge for 5 min, the supernatant fractions 
were subjected  to gel  electrophoresis  on 6%  SDS polyacrylamide  slab gels 
according to the procedure  of Laemmli  (39). Gels were fixed, in some cases 
prepared  for  fluorography  with  ENHANCE,  dried,  and  allowed to  expose 
Kodak X-Omat AR film at -70"C. Autoradiograms  were quantified  by scan- 
ning with an E-C Apparatus  Corp. (St. Petersburg, FL) EC910 densitometer 
tracer. 
Modifications of the standard  procedure were used in certain experiments. 
In the kinetic analysis, cells were incubated  with H23sSO4 at 10D60o unit/ml 
for 5 min (or 10  min for labeling of acid phosphatase).  Cultures  were then 
adjusted to 0.5% glucose, 1 mM ammonium sulfate, 100 #g/ml cycloheximide, 
to initiate  the  chase period.  Aliquots  of 1 ODin unit of cells were taken  at 
various times and added to chilled tubes that contained  10 #1 of 1 M sodium 
azide. Cells were washed once with cold 10 mM sodium azide and held at 0°C 
until  the  conclusion  of the  experiment.  In the  experiment  in  which  acid 
phosphatase  and invertase were both evaluated,  samples were split and one- 
half of each was treated with the respective antiserum. 
For treatment with endo H, aliquots of immunoprecipitated  invertase, after 
solubilization  in sample  buffer and separation  from  IgG Sorb, were diluted 
twofold  and  adjusted  to 0.1  mg/ml BSA, 0.1  M  sodium'acetate,  pH  5.1. 
Samples were incubated with 0.5 mU ofendo H overnight at 37"C. After being 
heated in boiling water, samples were subjected to SDS gel electrophoresis. 
N-Terminal  Analysis  of  Mutant  and  Wild-type  Inver- 
tase:  For N-terminal analysis of secreted invertase, strain SEY2102 contain- 
ing pRB58 with either SUC2 or the sl mutant was derepressed for invertase 
synthesis (40D6oo units of cells) in 2 ml of minimal medium with no sulfate 
and 0. 1% glucose. After l0 min at 25"C, 2 mCi of H23SSO4 were added to each 
sample for 60 rain at 25"C, and a chase period was initiated as described earlier 
for the  kinetic  analysis. Cells were centrifuged after a  60-rain  chase period, 
washed with l0 mM sodium azide, and converted to spheroplasts. Invertase in 
the E fraction was immunoprecipitated  as described earlier, using anti-invertase 
antibody  that had  been  afffinity-purified by adsorption  to and elution  from 
cytoplasmic invertase-conjugated to Sepharose 4B. The precipitates were solu- 
bilized in 30 td of sample buffer and separated from IgG Sorb by centrifugation; 
l ul of each was subjected to SDS gel electrophoresis to confirm the purity of 
the labeled samples. The remaining  samples were extracted twice with  l  ml 
acetone/triethylamine/acetic  acid (90:5:5) and then three times with acetone. 
Each extraction was incubated for 20 min at 0*C and then centrifuged at 12,000 
g for 10 rain. The final pellets were resuspended in 50 #l of l0 mM ammonium 
bicarbonate, 0.02% SDS. Samples were subjected to sequential Edman degra- 
dation using an Applied Biosystems (Foster City, CA) 470A gas-phase protein 
sequencer. Material released in each of the first 15 cycles was measured for 3SS 
counts per minute. 
For N-terminal analysis of ER-localized invertase, 5 ODin units ofSEY5188 
(secl8) containing pRB58 with either wild-type or sl mutant SUC2 genes were 
transferred to l  ml of minimal medium with 0. 1% glucose, no sulfate, and 4 
~M leucine. After 10 min at 25"C, 250 #Ci of [SH]leucine and 2 mCi H235SO4 
were added to each sample. Cells were incubated  for 60 rain at 37"C, washed 
with  10 mM sodium  azide, and converted to spheroplasts. Spheroplast pellet 
fractions  were  lysed, and  invertase  was  immunoprecipitated  with  afffinity- 
purified antibody and treated with endo H as described earlier. Samples were 
subjected to SDS gel electrophoresis on a 6% polyacrylamide gel that had been 
polymerized overnight and prerun for 5 min. The gel was dried without fixation 
and subjected to autoradiography.  Protein bands of interest were excised from 
the gel and electroeluted into dialysis tubing overnight at 4"C in 0.1  mM Tris- 
HCI, pH 8.0, 0.1% SDS, 0.1  mM sodium thioglycolate. Electroeluted samples 
were lyophilized to dryness and extracted twice with acetone/triethylamine/ 
acetic acid/water  (88:5:5:2) and three times with acetone as described earlier. 
The final pellets were resuspended in  10 mM ammonium bicarbonate, 0.02% 
SDS. Samples were subjected to sequential Edman degradation, and  15 cycles 
were counted  for 35S and 3H. in the samples of wild-type invertase, ~35,000 
cpm of 3sS was released at the indicated  cycle and ~2,000  cpm of 3H was 
released, sl  mutant invertase  samples  released  -16,000  cpm  of ~S  at the 
indicated cycle, and 1,000-1,500 cpm of  SH was released at each of  the indicated 
cycles. 
Release of Invertase  by Saponin:  To test the  solubility of the 
accumulated  invertases, 50 ODin units of SEY2102 cells, containing  an inte- 
grated copy of either SUC2-sl  or SUC2-s2, and SEY5186 (sec18 SUC2) were 
collected by centrifugation and washed once with water. Cells were resuspended 
in 50 ml of minimal medium and 0.1% glucose. After 2 h at 37°C, 50 ODin 
units were collected by centrifugation, washed with 10 mM sodium azide, and 
converted  to spheroplasts as described earlier, except at 50 ODt,0o U/ml and 
with 5,000 U/ml of lyticase. After 60 min incubation  at 30"C, spheroplasts 
were collected by centrifugation  for 5 rain at 3,000 g and washed once with 
spheroplast buffer without lyticase and 2-mercaptoethanol.  Spheroplasts were 
1666  THE  JOURNAL OF  CELL BIOLOGY , VOLUME 100, 1985 
then lysed in 50 mM KHaPO4, pH 7.5, 10 mM NuNs, a treatment that retained 
~80% of wild-type invertase in sec18 in a latent, sedimentable form. Aliquots 
of the lysed spheroplasts were adjusted to a range of saponin concentrations, 
incubated at 4"C for 60 rain, and then centrifuged at 133,000 g for 12 min in 
a Beckman airfuge (Beckman Instruments, Inc., Pulp Alto, CA) with an A100 
fixed-angle rotor.  Supernatant  fractions were removed and saved. Pellet frac- 
tions were resuspended to the original volume in 50 mM KH2PO4, pH 7.5, 10 
mM NAN3, 0.1% Triton X-100. Fractions were assayed for protein concentra- 
tion,  invertase  activity,  and  cytochrome  c  reductase  activity  according  to 
published  procedures  (protein  [40], invertase  [33], cytochrome  c  reductase 
[41]). 
Recombinant DNA and Marker Rescue Mapping:  Plasmid 
purification, agarose gel electrophoresis, transformation  of bacteria, and other 
DNA manipulations  were performed by standard methods (42). 
Wild-type, sl, and s2 SUC2 genes were subcloned into YIp5 (30) by ligation 
of a 4.5 base pair XhoI to Clal fragment of the SUC2 insert into YIp5 cut with 
Sail and Clal. Uncut Ylp5 containing wild-type and mutant SUC2 genes were 
then transformed  into SEY2102. URA ÷ transformants resulting from integra- 
tion of YIp5 into the genome were picked and assayed for invertase secretion. 
For construction of  mutant-wild type hybrid genes, SUC2 was first subcloned 
by inserting the HindIlI  fragment  of oRB58  into the unique Hindlll  site of 
pSEY8 (see Fig. 6).  The 800  base EcoRI-BamHl  fragment  in this  pSEY8 
construct  was then replaced with the  1,600 base EcoRI-BamH 1 fragment of 
SUC2-sl,  -s2, or -s3 from mutant pRB58  plasmids.  Hybrids then contained 
the 5' half of a mutant gene and the 3' half of wild-type SUC2. 
For marker rescue mapping, SUC2-sl,  -s2, and -s3 HindIlI  fragments were 
subcloned into the pSEY8 HindlIl cloning site, and the resulting plasmids were 
introduced  into yeast strain  SEY2102 (a SUC2-A9). SEY2102 (a SUC2-A9) was 
transformed  with  the  SUC2-1acZ  fusion  vectors  pSEYI25,  oSEYI24,  and 
pSEYI22 (29). Strains were mated pairwise on YPD plates, and after 1-2 d the 
mating patches  were resuspended  in water and spread  on minimal  medium 
plates +2%  sucrose, 0.02 mg/ml ergosterol, 0.25 mg/ml oleate,  2.5  mg/ml 
Tergitol Nonidet  P-40, and 20 #g/ml uracil. Plates were incubated  at 30"C in 
an anaerobic jar using the BBL-Gas Pak anaerobic  system. These conditions 
allowed growth only ofSUC* recombinants that were picked after 5-6 d. SUC  ÷ 
colonies were streaked on fresh plates and grown selectively for an additional 
4 d. Single colonies representing a number of  original recombinants were grown 
in liquid medium, and secretion and accumulation  of invertase were assessed 
as before. 
DNA Sequencing:  Preparations of  each of  the mutant SUC2 plasmids 
were digested with BamH 1 and Hindlll.  The 776 base fragment that contained 
the 5' half of each mutant SUC2 gene was purified by gel electrophoresis in 
and extraction  from low melting temperature  agarose (43). M I3 rap8 or M I3 
mp9 RF (replicative form) DNA was digested with HindliI  and BamH 1, and 
30 ng of this DNA was reacted with 200 ng of the SUC2 purified fragment in 
the presence of T4 DNA ligase. Ligated DNA was used to transfect  E.  coli 
JMI03  (44). Single-stranded  DNA was isolated  from cultures  grown  from 
individual recombinant  phage plaques and used as template for DNA sequenc- 
ing by the dideoxy chain termination  technique (45). M I3 mp8 and M I3 rap9 
have Hindlll  and BamHl  cloning  sites in  opposite  orientations.  M13  rap8 
provided coding strand  sequence for about 450 bases from the Hindlll site in 
the signal sequence coding region, while M I3 rap9 provided 450 base pairs of 
sequence on the noncoding strand  from the BamHl  site in the middle of the 
SUC2 gene. 
RESULTS 
Mutagenesis of Cloned SUC2 Gene 
A  2  ~  yeast  plasmid  containing the  SUC2  gene  and  a 
selectable marker gene (URA3) was mutagenized in vitro with 
hydroxylamine which produces C to T  transitions.  Mutant 
DNA was introduced by transformation into a  ura3  strain 
that contained a deletion in the SUC2 gene (28).  Hydroxyl- 
amine treatment was adjusted so that 10-15 % of the plasmids 
that were recovered by transformation contained SUC2 mu- 
tations  resulting  in  no  active  invertase.  The  efficiency  of 
transformation by DNA mutagenized at this level was reduced 
twofold for yeast and 104-fold for E. coil 
In a sampling of 60 independent suc- mutants, 31 failed to 
make any invertase  immunoreactive protein, which, in most 
cases, was due to major rearrangements in the plasmid DNA. 
Of the remaining 29 mutants in which immunoreactive ma- terial was detected, six produced forms with electrophoretic 
mobilities characteristic of invertase accumulated in the en- 
doplasmic  reticulum  (46).  These  mutations  may  produce 
denatured forms ofinvertase that can not be transported from 
the ER. 
To identify mutations that affect transport but not correct 
folding of the invertase polypeptide, we screened 6,000 inde- 
pendent transformants by procedures that detect intracellular 
accumulation of active invertase. Four were found that  fit 
this  criterion, and  the  extent of invertase accumulation is 
shown  in  Table  I.  Cells  transformed with  the  normal  or 
mutant (SUC2-s I to -s4) plasmids were derepressed for inver- 
tase  synthesis, converted to  spheroplasts,  and  the  released 
(periplasmic)  and  sedimentable  (intracellular)  activity  was 
measured. With the exception of mutant s4, nearly normal 
levels of invertase were produced (Table I, lines 1-5). All of 
the mutants showed at least fivefold accumulation of intra- 
cellular invertase, with sl  the most dramatic at 30-fold. In- 
vertase derepressed under steady-state conditions of growth, 
in raffinose, showed the same accumulation behavior (Table 
I, lines 6-8). Despite the reduced rate of invertase transport, 
cells carrying the mutant plasmids grew normally on sucrose- 
selective medium. 
Cytoplasmic invertase, a nonsecreted protein product of an 
alternative SUC2 transcript (26),  was examined by electro- 
phoresis of spheroplast extracts on a nondenaturing gel sys- 
tem. Mutants s 1, s2, and s3 produced normal amounts of this 
enzyme (not shown). Mutant s4 was eliminated from further 
consideration because the low amount of periplasmic inver- 
tase produced was less stable and cytoplasmic invertase was 
inactive. 
Cells transformed with the multicopy SUC2 plasmid pro- 
duced about  10-fold  more invertase than  was  detected in 
normal cells with a single-chromosomal SUC2 gene. To test 
whether overproduction of the mutant invertase contributed 
to  the  secretion-defective phenotype,  SUC2  mutant  genes 
were subcloned into the integrating plasmid YIp5 and recom- 
bined into the yeast genome. Whereas the amount ofinvertase 
dropped  10-fold, the extent of accumulation was unaffected 
(Table  I,  lines  9-11).  These  results  also  showed  that  the 
mutations were linked to SUC2. 
Mutants Defective in Transport of Core- 
glycosylated Invertase 
Invertase transport intermediates have been identified in 
pleiotropic sec mutants that are blocked at successive  stages 
in the secretory pathway. Mutants such as secl8,  in which 
transport from the ER to the Golgi body is blocked, represent 
the earliest stage where an active secretory form of invertase 
is detected. SDS gel electrophoresis of invertase accumulated 
in  secl8 reveals several discrete species of around  80  kd, 
corresponding to core-glycosylated  molecules. Subsequent ol- 
igosaccharide modifications in the Golgi body produces het- 
erogeneous, low electrophoretic mobility forms of invertase 
(46). 
To identify the site of accumulation of mutant invertase, 
we labeled cells (wild type and secl8) transformed with plas- 
mids carrying wild-type, SUC2-sl,  -s2, or -s3 mutant genes 
for 30 rain with 35SO42-, converted them to spheroplasts, and 
evaluated the periplasmic (external, E) and intracellular (I) 
fractions by immune precipitation and SDS gel electropho- 
TABLE  I 
Accumulation  of Active Invertase in SUC2 Mutants 
Derepressed 
intracellular  Periplasmic  Fold 
Line  Plasmid/SUC2 type  invertase*  invertase  Total activity  accumulation* 
UnitsIOD cells  % wild type 
1  pRB58/SUC2  0.40  1.71  100  1 
2  pR B58/SUC2-s  1  1.96  0.28  106  30 
3  pRB58/SUC2-s2  1.12  0.76  89  6.7 
4  pRB58/SUC2-s3  1.13  0.87  95  5.7 
5  pRB58/SUC2-s4  0.52  0.43  45  5.2 
6  pRB58/SUC2  0.04  0.77  I00  1 
7  pRB5815UC2-s1  0.60  0.35  117  34 
8  pRB58]SUC2-s2  O. 16  0.53  85  6 
9  YIp5ISUC2  0.03  0.29  100  1 
I0  YIp5]SUC2-sl  0.15  0.05  63  33 
11  YIp5/SUC2-s2  0.27  0.22  150  12 
12  s  SUC-sl  0.74  O. 12  62  36 
pRB58/Eco-Barn hybrid 
13  SUC2-s2  0.71  0.90  116  6 
pRB58/Eco-Bam hybrid 
14  SUC2-s3  0.55  0.83  99  5.1 
pRB58/ E_co-Bam hybrid 
* SEY2102 was transformed with the indicated plasmids. Except in the experiment in lines 6-8, cells were grown to mid-log phase in selective minimal medium 
and 5% glucose, washed, and derepressed for 3-4 h at 25°C in minimal medium and O.1% glucose. Cells were converted to spheroplasts and centrifuged, 
and the supernatant (periplasmic) and pellet (intracellular) fractions were assayed  for invertase  activity. A constant  background of cytoplasmic invertase  activity 
was subtracted to give the derepressed intracellular level. Cells in the experiment in lines 6-8 were grown in minimal medium and 2% raffinose. 
The ratio of derepressed intracellular to periplasmic activity for mutant SUC2  alleles divided by the ratio for wild-type SUEZ 
! Results of a separate experiment with values normalized to assays of pRBS8/SUC2  done in parallel. 
SCHAUER ET A/.  Invertase  Transport  Mutants  ] 667 resis.  After this labeling period in wild-type cells containing 
pRB58, the cytoplasmic invertase and some of the ER transit 
form were found in the I fraction, while much of the invertase 
was highly glycosylated and in the E fraction (Fig.  l). The ER 
transit  forms accumulated  in  secl8  were  similar to  those 
found  in  wild-type cells.  SUC2-sl,  -s2,  and  -s3  produced 
nearly exclusively ER transit forms of invertase. Mutant sl 
(and s2,  not shown)  showed the  same behavior when inte- 
grated into the chromosome (single  copy). Unlike the pleio- 
tropic sec mutants, the SUC2 transport mutants were blocked 
to the same extent at 25 ° and 37"C (not shown). Hence, by 
comparison with the  behavior of seclS, the SUC2 mutants 
appear to be nonconditionally defective in transport from the 
ER, or possibly from a compartment between the ER and the 
site of outer chain carbohydrate addition. 
In  experiments with  longer radiolabeling  periods,  highly 
glycosylated,  secreted  invertase  was  detected  in  cells  that 
contained the  sl,  s2,  and  s3  mutant alleles.  The possibility 
that these mutants were not absolutely defective in transport 
allowed additional definition of the stage in the pathway and 
of the specificity of the defects. 
If the transport-defective invertase is delayed in the secre- 
tory pathway before or concurrent with the SEC18 dependent 
step, then invertase that accumulates at 25"C will not progress 
beyond the secl8 block at 37"C. On the other hand, if mutant 
invertase is delayed beyond the SECI8 step, progress will not 
be hindered  in secl8 cells at 37"C. secl8 cells,  transformed 
with a plasmid carrying SUC2-s3,  were labeled with 35SO42- 
for  l0  min  at  24"C  (sec  permissive temperature).  Culture 
aliquots were subsequently incubated for 30 and 60  rain at 
24* and 37"C (sec nonpermissive temperature) in the presence 
of cycloheximide.  Intracellular and  external  invertase  was 
examined by immunoprecipitation (Fig.  2).  After the pulse, 
only core-glycosylated  invertase in the I fraction was observed. 
With increasing chase time at 24"C,  heterogeneous glycosy- 
lated material was detected in the E  fraction, with a  corre- 
sponding decline in core-glycosylated  protein in the I fraction. 
No further glycosylation or secretion was seen when the chase 
was conducted at 37"C. This pattern was qualitatively similar 
in mutants sl and s2, suggesting that all the invertase defects 
delay transport before or at the SEC18 step. Control experi- 
ments  with  wild-type  cells  containing  mutant  invertase 
showed secretion of about one-half of the sl  invertase, and 
all of the s2 mutant protein, during the 60-min chase at 37"C. 
Differences among the invertase mutants were uncovered 
by a  more detailed  analysis of the  kinetics  of secretion  at 
24"C.  Ceils that  carried plasmids with  wild-type,  sl,  or s2 
invertase were pulse-labeled for 5 min. At various times during 
subsequent incubation in the presence of cycloheximide, sam- 
ples were withdrawn and the distribution of immunoreactive 
forms of invertase was evaluated. Fig. 3 shows the percentage 
of radiolabeled  invertase (open  symbols, core glycosylated; 
closed symbols, heterogeneous forms) that remained intracel- 
lular at the indicated times of chase. In the pulse label, 60% 
of the wild-type invertase was core glycosylated and intracel- 
lular,  whereas the  highly glycosylated material was equally 
divided  between  intracellular  and  secreted.  Conversion  of 
core- to highly-glycosylated invertase occurred with a lj/2 of 
~1.5 min for the wild-type, -75 min for mutant sl, and -10 
rain for mutant s2 (same as s3, not shown). A semilogarithmic 
plot  of the  data  for the  mutants  revealed  a  single  kinetic 
constant for conversion of invertase. In each case, the total 
amount  of labeled  invertase remained  constant  during  the 
chase period. A transient increase in highly glycosylated intra- 
cellular invertase was seen early in the chase period of wild- 
type protein, while mutant sl and s2 showed negligible  intra- 
cellular levels of this form. These results suggest that mutants 
s 1 and s2 are distinct, and that secretion is specifically delayed 
in the ER with no observable effect on subsequent transport 
from the Golgi body. 
Additional  evidence  for  the  specificity  of the  invertase 
mutations came from an analysis of acid phosphatase secre- 
tion  and growth rates of strains that  contained the  mutant 
SUC2 plasmids. A strain that carries the pho80-2  mutation, 
and therefore constitutively makes and secretes acid phospha- 
tase (47),  was transformed with wild-type or mutant SUC2 
plasmids. Cells were derepressed for invertase expression and 
labeled for  l0 min at 25"C,  and samples were withdrawn at 
intervals during a chase in the presence of cycloheximide. The 
distribution  of radiolabeled forms of acid  phosphatase was 
FIGURES  1  Immunoprecipitation and electrophoresis of wild-type and mutant invertases. SEY2102 cells transformed  with pRB58 
containing either  wild-type  or  mutant  SUC2 genes  and  SEY5188 (secl8)  containing pRB58  were  derepressed  for  invertase 
expression  and labeled with 3sSO42- for 30 min. Samples were separated  into spheroplast  pellet (/) and spheroplast  supernatant 
(E) fractions and immunoprecipitated with invertase  antiserum.  Immunoprecipitates were analyzed  by SDS PAGE and autora- 
diography, mature, highly glycosylated invertase;  ER, core-glycosylated invertase characteristic  of endoplasmic reticulum forms' 
cyto, cytoplasmic invertase. 
1668  THE  JOURNAL  OF  CELL  BIOLOGY  • VOLUME  100,  1985 FIGURE 2  Secretion of s3 mutant 
invertase  blocked  in  secl8  at 
37*C. SEY5188  (secl8) cells trans- 
formed  with  pRB58  that  con- 
tained SUC2-s3 were derepressed 
for  invertase  expression  and  la- 
beled with ssso42- for 10 min at 
25"C. Immediately after initiation 
of the chase period by addition 
of glucose, unlabeled sulfate, and 
cycloheximide, an aliquot of the 
culture was transferred  to  37°C 
and the  rest  was  kept  at  25"C. 
Aliquots  were  taken  at  various 
times, separated into spheroplast 
pellet (I)  and spheroplast  super- 
natant  (E)  fractions,  and  immu- 
noprecipitated  with  invertase 
antiserum.  Immunoprecipitates 
were analyzed by SDS PAGE and 
autoradiography. 
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FIGURE 3  Kinetics  of wild-type and  mutant  invertase  secretion. 
5EY2102 cells  that  contained  either the wild-type or s2  mutant 
SUC2 genes were derepressed for invertase expression and labeled 
for 5  rain  with 35SO42-. Chase was initiated with the addition of 
glucose, unlabeled sulfate, and cycloheximide.  Aliquots were taken 
at various times, separated into spheroplast  pellet and supernatant 
fractions,  and  immunoprecipitated with  invertase  antiserum.  Im- 
munoprecipitates were subjected  to SDS PAGE and fluorography. 
Cross-reacting material was quantified by densitometric scanning. 
evaluated by immunoprecipitation and SDS gel electropho- 
resis.  As with invertase, acid phosphatase undergoes a  core- 
to highly-glycosylated conversion after transport to the Golgi 
body (46). Core-glycosylated acid phosphatase was converted 
and  secreted  at the  same rate  in  cells that were producing 
wild-type or mutant invertase (not shown). In the same sam- 
ples,  the pattern of invertase glycosylation and secretion was 
identical  to that  seen in  Fig.  3.  Furthermore, the  invertase 
mutants did not interfere with any essential aspect of growth; 
doubling times in derepressing media were the same for cells 
carrying wild-type or SUC2 mutant plasmids. 
Physical Properties of the  Mutant Invertases 
Delayed secretion of mutant invertase could be accounted 
for by aberrant subunit interaction or aggregation within the 
lumen  of the  ER.  This possibility was tested by native gel 
electrophoresis  of invertase  released  from  membranes  by 
treatment  with  Triton  X-100.  Secreted  invertase,  detected 
with an activity stain,  migrates as a  heterogeneous mixture, 
whereas enzyme accumulated in  the ER  (such as in secl8) 
displays four discrete species which appear to be multimeric 
forms of the active dimer (46). For comparison, wild-type and 
sec18 cells containing SUC2, SUC2-sl (on a multicopy plas- 
mid or integrated), -s2,  or -s3 were derepressed for invertase 
synthesis and fractionated as before. Fig. 4 shows the pattern 
described above for wild-type and sec18 cells. The intracellular 
enzyme produced  by  mutants  s2  and  s3  migrated  as  did 
invertase in sec18. Mutant s l, however, appeared aggregated 
with  a  heterogeneous  and  low  electrophoretic  mobility.  A 
pattern  more  like  that  of secl8  was  seen  with  cells  that 
contained a  single copy of mutant sl, although most of the 
invertase was concentrated in the lowest mobility forms. 
While Triton X-100 quantitatively released the  ER-accu- 
mulated  forms of invertase, at least one ER  integral mem- 
brane  protein,  NADPH-cytochrome c  reductase,  was  also 
solubilized. To address the issue of invertase solubility in the 
ER lumen, saponin, a detergent that permeabilizes but does 
not solubilize the ER membrane, was used to examine release 
of invertase activity from the  membrane fraction.  Sphero- 
plasts made from cells (wild type or sec18) that had accumu- 
lated  normal  or  mutant  invertase  were  osmotically  lysed 
under conditions that  retained invertase in  a  sedimentable, 
presumably  ER-bounded  form.  Extracts  were  mixed  with 
various  amounts  of saponin  at  0*C, and  the  amounts  of 
sedimentable protein, NADPH-cytochrome c reductase, and 
invertase were assessed.  Fig.  5 shows that very little protein 
(top) and no NADPH cytochrome c reductase (middle) were 
solubilized by saponin concentrations as high as 0.6 mg/mg 
protein.  Wild-type  invertase  accumulated  in  secl8  and  s2 
mutant invertase were readily released (70-80%  solubilized; 
Fig.  5,  bottom)  by  saponin  at  0.2-0.3  mg/mg protein.  In 
contrast, only ~35% of the sl  mutant invertase was released 
by saponin.  S 1 mutant enzyme that resisted saponin extrac- 
tion was solubilized with 0.1%  Triton X-100 and compared 
with the saponin-released invertase by native gel electropho- 
resis.  Heterogeneous, low-mobility invertase was enriched in 
the saponin pellet fraction and discrete, higher-mobility forms 
were recovered in the saponin soluble fraction (not shown). 
Hence, by the native gel electrophoresis and saponin solubility 
criteria, sl  mutant invertase appears to be aggregated and to 
some extent associated with the ER membrane, whereas the 
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electrophoresis of wild-type and 
mutant  invertase.  SEY2102 cells 
containing  either  wild-type  or 
mutant SUC2 genes and SEY5188 
(seclS)  cells containing the wild- 
type  5UC2  gene  were  dere- 
pressed  for  invertase  expression 
for 3 h and separated into spher- 
oplast  pellet  (I)  and  spheroplast 
supernatant (E) fractions.  Samples 
were subjected to nondenaturing 
gel  electrophoresis,  and  the  gel 
was stained for invertase activity. 
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FIGURE 5  Saponin  solubilization  of  accumulated  invertase. 
SEY2102 cells that contained the mutant SUC2 genes and SEY5188 
(seclS) cells  with the wild-type 5UC2 gene were derepressed  for 
invertase  expression  and  converted  to  spheroplasts.  Sedimented 
spheroplasts  were lysed  by osmotic shock.  Aliquots were treated 
with different saponin concentrations and centrigued at 133,000 g. 
Pellet and supernatant fractions were assayed for invertase activity 
(bottom),  NADPH-cytochrome  c  reductase  activity (middle),  and 
total protein (top). Values  represent  the fraction sedimentable rel- 
ative to the no detergent control. O, seclS; O, SUC2-sl; A, SUC2- 
s2. 
s2 mutant enzyme is indistinguishable from normal invertase 
accumulated in  the  ER  lumen,  s2 and s3  mutant enzymes 
were identical in these characteristics. In other experiments, 
the mutant invertases had heat stability properties similar to 
those of the wild-type enzyme. 
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Mapping and Sequencing the SUC2 Mutations 
Since the SUC2 mutants were derived from DNA that was 
heavily mutagenized, it was likely that the isolates contained 
multiple mutations. For this reason, it was essential to localize 
the phenotypically important mutations by genetic mapping. 
We localized  the  transport-deficient mutations to the  5' 
half of SUC2 by subcloning a  1,600 base pair EcoR 1-BamH 1 
fragment from the mutant DNA, containing about 770 bases 
of the 5' coding region, into a  vector that contained the  3' 
half of wild-type SUC2.  Donor and  recipient plasmids are 
diagrammed in  Fig.  6.  Yeast transformants that  contained 
the hybrid constructs showed the same invertase accumula- 
tion  phenotype  of the  parents  (Table  I,  lines  12-14).  The 
accumulated material was examined by nondenaturing and 
SDS gel electrophoresis, and with one minor exception, the 
original phenotypes were reproduced. In the original sl  iso- 
late, cytoplasmic invertase migrated more slowly than normal 
on a nondenaturing gel (Fig.  4). The EcoRI-BamHl  hybrid 
of mutant sl  produced a  normal cytoplasmic invertase (not 
shown),  suggesting  that  the  3'  half of the  original  isolate 
contained at least one additional  mutation that had no de- 
tectable influence on invertase transport. 
To localize the transport mutations more precisely within 
the  5'  coding region,  we devised a  form of marker rescue 
recombinant analysis. HindlII fragments from plasmids car- 
rying SUC2-sl, -s2, and -s3 were subcloned into the HindlII 
site of pSEY8 (Fig.  6). These constructs were missing the 5' 
regulatory sequences and  the  first  10 bases coding  for the 
secreted form of invertase. Cells transformed with these plas- 
mids were  mated with  cells carrying another plasmid that 
contained one of a series of gene fusions in which a portion 
of the wild-type SUC2 5' regulatory and coding sequence was 
fused to a nearly full-length fragment of the E. coli lacZ gene 
(29).  Neither  construct  allowed  invertase  synthesis;  conse- 
quently, anaerobic growth of diploid strains on sucrose pro- 
vided a selection for recombinants that generated functional 
invertase. Since the presence of even the sl mutant invertase 
allowed growth on sucrose, wild-type and transport-deficient 
recombinants were generated. Wild-type recombinants could 
be generated only if the region containing the transport mu- pBR322 
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Plasmids  for  hybrid  SUC2  mapping,  pRB58  contained the  SUC2  gene and  pSEY8 provided a  region with  many 
convenient restriction sites. H, Hindlll; R, EcoR1; B, BamH1; X, Smal; S, Sail; P, Pstl. 
SUC2 
5'  regulatory 
-  sequences  ~ 
AUG~ 
Loc Z 
5' truncated  mutant  SUC2  cjene 
FIGURE  7  Marker rescue recombinational mapping of SUC2  mutants. The strategy for recombinational mapping of the SUC2 
mutations is outlined. Plasmids carried either a 5UC2-/acZ fusion (top) or a 5'-truncated mutant SUC2 gene (bottom). A, t3, and C 
are hypothetical mutations and the long arrow between the two plasmids is one possible SUC2 + recombinant. 
tation was represented on the SUC2 lacZ fusion. The ratio of 
wild-type and mutant recombinants was an approximate mea- 
sure  of the  position  of the  mutation  within  the  region  of 
homology. This point is illustrated  in  Fig.  7:  Mutations  in 
region A  would  give mainly wild-type recombinants,  in  B 
would  yield a  mixture of mutant  and  wild-type, and  in  C 
would  produce  only mutant  recombinants.  Fig.  8  presents 
data on the percentage of wild-type recombinants generated 
in crosses between each mutant and hybrid genes that con- 
tained  150, 600, or 800 bases of SUC2. Mutant sl  showed a 
high  percentage  of wild-type  recombinants  even  with  the 
smallest SUC2 fusion tested. Mutants s2 and s3 showed wild- 
type recombinants only with the  next larger SUC2  fusion. 
The possibility that transport mutations are 5' to the HindlII 
site in the coding sequence is eliminated by these data. Ap- 
proximate map positions for these mutations are indicated in 
Fig. 8. Additional mutations required for the transport defect 
could reside between the marker rescue site and the BamH 1 
site in the middle of the gene. 
The transport mutations were defined  precisely by DNA 
sequence analysis of the 776 base HindlII-BamH 1 fragment 
from each  mutant  plasmid.  SUC2-sl  contained  two  muta- 
tions in this region. One silent mutation resulted in exchange 
ofphe codons at amino acid position 150 (TTC to TTT). The 
important mutation produced a change in the final codon of 
the signal peptide from ala to vat (GCA to GTA). Although 
SUC2-s2 and -s3 mutations were derived from separate sam- 
ples  of mutagenized  DNA,  they  both  contained  the  same 
single  substitution  resulting in  ile  in  place of thr (ACT to 
ATT) at position +64 in mature invertase. Two segments of 
the invertase protein sequence in the area of mutations sl and 
s2 are shown in  Fig.  9.  A  close correspondence was found 
between the map position determined by marker rescue re- 
combinant analysis and DNA sequencing of the mutations. 
Signal Peptide  Processing of Mutant Invertase 
Secreted invertase is processed from a precursor that con- 
tains a  19 amino acid signal peptide (48).  Since valine is not 
found on the N-terminal side of signal peptide cleavage sites 
(49), SUC2-sl  mutant invertase could be defective in cleavage 
by signal peptidase. Retention of the signal peptide on mutant 
invertase was assessed by treatment of accumulated and se- 
creted material with endo H. sec18 and wild-type cells con- 
taining the SUC2, -s l, or -s2 plasmids were radiolabeled with 
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(150bp)  (40)  (47)  (36) 
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FIGURE  8  Mutations map to a region of <_250 
base  pairs  at  the  5'  end  of  the SUC2 gene. 
SEY2102 cells  containing  5'  truncated  con- 
structs of the mutant SUC2 genes were mated 
with  SEY2101 containing three different  size 
classes of  SUC2-1acZ fusions.  PSEY125 con- 
tained  150  bases, pSEY124 contained  600 
bases, and  pSEY122 contained 800  bases of 
5UC2 coding  sequence. The  table  gives  the 
percentage  of  wild-type  recombinants  from 
each cross. The number in  parenthesis  is the 
number  of  recombinants  analyzed  for  each 
cross. The sketch  shows the approximate po- 
sitions of the mutations predicted by the map- 
ping data. 
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FIGURE  9  Amino acid changesin SUC2transport mutants. 
355042- for 30 min and converted to spheroplasts, and the I 
and E fractions were treated with invertase antibody. Samples 
of the immunoprecipitates were treated with endo H  under 
conditions  where all the  oligosaccharides are cleaved from 
invertase.  Untreated  and  deglycosylated invertase  samples 
were compared by SDS gel electrophoresis. Endo H treatment 
produced a form with an apparent Mr of 58,500 for normal 
invertase accumulated in secl8,  and s2 invertase in normal 
cells (Fig.  10). The difference of-2.5 kd between this species 
and the cytoplasmic invertase was expected from the  10-12 
GIcNAc residues that remain after endo H  treatment. Two 
forms of deglycosylated sl  invertase of approximately equal 
abundance were seen in the I fraction. One was the 58.5-kd 
species and the other was a 61-kd form corresponding to an 
increment expected for retention of the signal peptide. The 
same  2.5-kd  size  difference  was  seen  in  a  comparison  of 
unglycosylated s 1 and wild-type invertase produced in tuni- 
camycin-treated cells (not  shown).  By this criterion,  signal 
peptide processing was normal for mutant s2 but defective for 
sl mutant invertase. 
After a chase period of 2 h, invertase secreted in mutant sl 
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was in the usual highly glycosylated form. Only the 58.5-kd 
species was detected when this material was treated with endo 
H  (Fig.  10). Since  the  immunoreactive  invertase  was  re- 
covered in  good  yield  after the  chase  period,  some of the 
glycosylated precursor must have been proteolyticaUy proc- 
essed en route to the periplasm. 
To confirm the accumulation of unprocessed invertase, and 
to determine the site of cleavage of the mutant protein, we 
performed sequential Edman degradation of 35SO42--[3H]leu  - 
cine  double-labeled  proteins.  Wild-type forms of invertase 
accumulated in sec18, or secreted in a wild-type strain, were 
removed from SDS gels of samples that had been treated with 
endo H. Table II shows that 35S was released in the second 
cycle of Edman degradation and 3H was released in cycle 11. 
This was expected from the location of met and leu in mature 
invertase at position 2 and 1 1, respectively, sl invertase that 
accumulated in a wild-type cell in the apparently unprocessed 
and processed forms were compared with the mutant secreted 
form by the same analysis. As expected from the sequence of 
the gene, 35S was released from the unprocessed form in cycle 
1, and 3H in cycles 2, 3, 7, 9, and 10. In contrast to wild-type FIGURE  10  Endo H  treatment of 
wild-type and  mutant invertases. 
S  EY5188 (secl8) transformed with 
the  SUC2  plasmid  and  SEY2102 
transformed  with  mutant  plas- 
mids were derepressed for inver- 
tase expression and labeled with 
35SO42-  for  30  min  (37°C  for 
SEY5188  and 25°C for SEY2102). 
A  portion of the SEY2102  culture 
was incubated an  additional 2  h 
under conditions of chase. Spher- 
oplasts formed from each sample 
were  sedimented,  and  invertase 
immunoprecipitated  from  the 
pellet (/} and supernatant (E) frac- 
tions as before. Samples of each 
were  treated  with  endo  H  and 
compared  with  untreated  mate- 
rial  by  SDS  gel  electrophoresis 
and autoradiography. 
TABLE  II 
S  1 Signal Cleavage Occurs at an Alternate Site 
3sSO4 in 
cycle  [3H]leu in cycle 
ER  2  11 
5UC2 
Secreted  2  ND 
SUC2-s 1 
ER-unprocessed  1  2, 3, 7, 9, 10 
ER-processed  1  10 
Secreted  1  ND 
1  2  3  7  9  10 
met-leu-leu-gln-ala-phe-leu-phe-leu-leu-ala-gly-phe-ala-ala-lys-ile- 
i  2/1  11/10  ala  ser-va I- ser- met-thr-asn-g[u-thr-ser-asp-arg-pro-leu 
T  ? 
ND, not determined. 
* Normal cleavage site. 
* sl mutant cleavage site. 
processed invertase, 35S was released in cycle 1 of  the processed 
mutant form, and 3H in cycle 10 of the accumulated form. 
Hence, the val-ser bond was not cleaved in sl  mutant inver- 
tase;  instead,  the  adjacent  ser-met bond  was  cleaved  at  a 
reduced rate. 
DISCUSSION 
Lesions  in  a  transport  signal  could,  by  means  of genetic 
suppressor analysis, lead to the definition of interacting pro- 
teins that mediate transport. As a first step in this approach, 
we have designed a screening procedure to detect mutations 
in the invertase structural gene that specifically affect secre- 
tion.  By insisting  on  retention  of full  enzyme activity, we 
should avoid mutations that simply result in denatured pro- 
tein precipitated in the lumen of a secretory organelle. As an 
illustration  of this  point,  of 29  independent  suc2  mutant 
isolates that produce enzymatically inactive invertase cross- 
reacting material,  six  were found to  accumulate in  a  core- 
glycosylated form.  These mutations most likely yield dena- 
tured invertase that remains in the ER. 
Starting with extensively mutagenized SUC2 plasmid DNA, 
only three out of 6,000 transformants were found that accu- 
mulate active, stable invertase. Of these, two contain the same 
mutation. The distinct mutations, SUC2-sl and -s2, produce 
fully active forms of invertase which are delayed in transport 
from the ER (or possibly some post-ER compartment) to the 
Golgi body, but not to a similar extent in subsequent export 
to the  cell  surface. This delay is considerably greater for sl 
than s2. 
Signal peptide cleavage in the sl  mutant invertase is defi- 
cient owing to the substitution of val for ala at position -  1 of 
the cleavage site.  Retention  of the  signal  peptide on  about 
half of the  sl  molecules causes invertase to  form irregular 
assemblies, as detected by electrophoresis in a nondenaturing 
gel system. These assemblies remain associated with ER mem- 
branes permeabilized  by a  weak  detergent,  saponin,  while 
being readily solubilized by Triton X-100. The other half of 
the accumulated sl  invertase, which  has a  polypeptide size 
characteristic of the  proteolytically processed form, may be 
retained by normal subunit association with the unprocessed 
subunits.  Alternatively,  as this  material is  processed at the 
adjacent peptide bond, met-terminated invertase may be in- 
herently transport defective. 
The mutant invertase is cleaved at a  reduced  rate at the 
adjacent ser-met bond.  This alternate site has, according to 
von Heijne's rules (49), roughly equal probability of cleavage 
in the normal invertase signal peptide. Substitution of val at 
the  normal site increases the  probability of cleavage at the 
alternate  site.  Additional  substitutions  at  the  ser  site  may 
further reduce processing and  secretion of invertase so that 
cells  would be unable to grow on sucrose or raffinose as a 
carbon  source.  Such  a  situation  could  be  used  to  obtain 
extragenic suppressor mutations among which  signal pepti- 
dase mutants with altered substrate specificity may be found. 
It is not clear why the failure to remove a  signal peptide 
has such  a  dramatic effect on  invertase transport  from the 
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accumulated s l  invertase  suggests  that unprocessed enzyme 
either associates  with a stable ER component or aggregates to 
a point where proper packaging for transport  is hindered.  In 
either  case,  the accumulation has no effect  on transport  of 
acid phosphatase, or cell surface growth,  so it is unlikely that 
mutant invertase  associates  with and titrates  some essential 
ER component. 
Other  similar  effects  of signal  peptide cleavage inhibition 
have been noted. Haguenauer-Tsapis and Hinnen (50) have 
deleted the cleavage site region of the yeast acid phosphatase 
gene (PH05) and find unprocessed, core-glycosylated enzyme 
accumulated within  the  cell  which  is  only slowly  secreted. 
Hortin and Boime (51,  52) report that incorporation of the 
threonine analogue, B-hydroxynorvaline, at the preprolactin 
signal  cleavage site  blocks proper processing.  Precursors  ac- 
cumulate in the ER in the unprocessed and in an alternatively 
processed  form.  This  material  is  unstable  and  only slowly 
secreted  in small amounts into the medium. Solubility and 
membrane association  of the unprocessed preprolactin  and 
acid phosphatase have not been investigated;  however, failure 
to cleave the signal  peptide of a mutant form of bacterial  ~- 
lactamase  results  in  association  of the  precursor  with  the 
external  surface of the cytoplasmic membrane (53). 
There are many examples of proteins with uncleaved signal 
peptides,  such as yeast a-factor (54), which nevertheless  are 
transported  rapidly  from the ER. What then is the function 
of signal  peptide cleavage?  Wickner (55) has suggested  that 
folding of membrane proteins and perhaps secretory proteins 
is influenced by the signal peptide.  If so, signal peptide cleav- 
age early in the synthesis of a precursor could ensure correct 
folding. This appears not to be the case for sl mutant invertase 
and cleavage-deficient  acid phosphatase (50);  both are  fully 
active enzymes. Perhaps certain signal peptides are cleaved to 
prevent association with a  stable  component of the ER. In 
this regard, some proteins are designed to remain in the ER, 
and  may  retain  the  signal  peptide  as  a  specific  anchoring 
segment. 
s2 mutant invertase shows slow transport from the ER with 
no delay in signal  peptide cleavage.  With regard to enzyme 
activity, electrophoretic  mobility, ease of release from the ER, 
and temperature stability,  s2 mutant invertase  resembles the 
normal  enzyme accumulated  in  the  ER  in  the  pleiotropic 
mutant secl8. Although the mutation results in a hydrophobic 
substitution (thr ---, lie at position +64), no effect  on subunit 
interaction  or solubility in the presence  or absence of deter- 
gent was detected.  The effect  on transport  could be due to a 
subtle conformational change that influences mutant enzyme 
concentration in a transitional  zone of the ER, or to defective 
interaction  with a receptor that mediates invertase movement. 
It  is  unlikely  that  the  transport  delay  results  from  some 
nonspecific  interaction  between  s2  mutant invertase  and a 
membrane  component  because  no  block  occurs  in  transit 
from the Golgi body to the cell surface. 
If the s2 mutation interferes  with an ER transport  signal, 
the interaction between mutant invertase  and a receptor may 
be only partly defective, or the slower rate of transport  may 
reflect  a basal  level of receptor-independent flow of soluble 
proteins  to  the  Golgi  body.  These  possibilities  would  be 
distinguished  by the isolation of additional SUC2 mutations 
outside the signal peptide region that further slow the rate of 
transport. 
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